Lexapro and Inapsine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lexapro (escitalopram oxalate) and Inapsine (droperidol). Common drug interactions include anaemia among females and heart rate decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Lexapro and Inapsine. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Lexapro?

Lexapro has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 91,464 Lexapro users. Check the latest studies of Lexapro.

What is Inapsine?

Inapsine has active ingredients of droperidol. eHealthMe is studying from 260 Inapsine users. Check the latest studies of Inapsine.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 24, 2026

15 people who take Lexapro and Inapsine together, and have interactions are studied.

What are the common drug interactions of Lexapro and Inapsine, by gender? *:

female:

Anaemia (lack of blood)
Arteriosclerosis (thickening and hardening of arteries)
Arthralgia (joint pain)
Chest pain
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Hypertension (high blood pressure)
Hypokalaemia (low potassium)
Mitral valve incompetence (inefficient heart valve)
Nausea (feeling of having an urge to vomit)
Pleural effusion (water on the lungs)

male:

Heart rate decreased
Hypotension (abnormally low blood pressure)

What are the common drug interactions of Lexapro and Inapsine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Abdominal pain
Alopecia (absence of hair from areas of the body)
Asthenia (weakness)
Back pain
Cystitis (inflammation of the wall of the bladder)
Decreased appetite
Diarrhoea
Dizziness
Hyperhidrosis (abnormally increased sweating)
Insomnia (sleeplessness)

30-39:

Cellulitis (infection under the skin)
Cervical dysplasia (abnormal changes in the cells on the surface of the cervix)
Cold sweat
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Cough
Crying
Cyst (a closed sac)
Dehydration (dryness resulting from the removal of water)
Drug abuse
Drug abuser

40-49:

n/a

50-59:

n/a

60+:

Asthenia (weakness)
Cardiac failure congestive
Arteriosclerosis (thickening and hardening of arteries)
Arthralgia (joint pain)
Atelectasis (partial or complete collapse of the lung)
Chest pain
Constipation
Contusion (a type of hematoma of tissue in which capillaries)
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

What are the existing conditions these people have? *

Pain: 5 people, 33.33%
High Blood Pressure: 5 people, 33.33%
Stress And Anxiety: 3 people, 20.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 20.00%
Gastric Ph Decreased: 3 people, 20.00%
Fatigue (feeling of tiredness): 3 people, 20.00%
Bacterial Infection: 3 people, 20.00%
Acne (skin problems that cause pimples): 3 people, 20.00%
Insomnia (sleeplessness): 2 people, 13.33%
Nausea (feeling of having an urge to vomit): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Lexapro and Inapsine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously